Histology and Cytology Market Report 2024

The histology and cytology market size has grown rapidly in recent years. It will grow from $15.29 billion in 2023 to $17.12 billion in 2024 at a compound annual growth rate (CAGR) of 11.9%. The growth during the historic period can be attributed to the high prevalence of chronic diseases, increasing healthcare expenditure, technological innovations in imaging, the expansion of research activities, and the aging global population.

The histology and cytology market size is expected to see rapid growth in the next few years. It will grow to $27.19 billion in 2028 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to the increasing prevalence of cancer, rising demand for personalized medicine, growing healthcare infrastructure in emerging markets, technological innovations in imaging techniques, an expanding geriatric population, and heightened research and development activities in life sciences. Major trends during this period include the increasing adoption of automation, rising demand for digital pathology, growth in personalized medicine, advancements in tissue staining technologies, expansion of research in oncology, a greater focus on workflow efficiency, and higher investments in laboratory infrastructure.

The increasing prevalence of cancer is expected to drive the growth of the histology and cytology market moving forward. Cancer encompasses a broad group of diseases characterized by the uncontrolled growth and spread of abnormal cells in the body. These cells can invade and destroy normal tissue and potentially spread to other parts of the body (metastasis). Several factors contribute to the prevalence of cancer, including an aging population, poor diet, lack of physical activity, excessive alcohol consumption, industrial pollutants, and inherited genetic mutations. Histology and cytology play essential roles throughout the cancer care continuum, from initial diagnosis and treatment planning to monitoring response, significantly impacting patient outcomes in oncology. For example, in May 2021, the National Library of Medicine, a US-based medical library, reported that the number of cancer cases worldwide is predicted to reach 28.4 million by 2040, a 47% increase from 2020, with an elevated death toll. Therefore, the increasing prevalence of cancer drives the growth of the histology and cytology market.

Major companies operating in the histology and cytology market are focused on developing advanced technologies, such as high-speed cell imaging, to maintain their market position. High-speed cell imaging captures rapid cellular processes with high temporal resolution, essential for studying dynamic events such as cell division, intracellular transport, signaling dynamics, and cell-environment interactions. For instance, in June 2022, Becton, Dickinson, and Company, a US-based medical device company, launched a new cell sorting device featuring two innovative technologies that enable scientists to observe more specific cell data previously undetectable with conventional flow cytometry tests. This innovative device combines spectral detection with high-speed imaging, allowing real-time analysis of multiple cell characteristics. It enhances precision by discerning subtle differences in cellular properties, such as fluorescence intensity and emission spectra, which are crucial for accurately sorting heterogeneous cell populations. This breakthrough promises to accelerate biomedical discoveries, advance cell-based therapies, and enable personalized medicine by providing unparalleled insights into complex cellular behaviors and interactions in unprecedented detail.

In June 2022, StatLab Medical Products, a US-based developer of medical diagnostic supplies and equipment, acquired CellPath Ltd. for an undisclosed amount. This acquisition will enable StatLab to broaden its product portfolio with CellPath's histopathology and cytology offerings, including reagents, consumables, and laboratory equipment. CellPath Ltd. is a UK-based manufacturer and supplier of products and services focused on histology and cytology.

Major companies operating in the histology and cytology market are Thermo Fisher Scientific Inc., Roche Diagnostics International Ltd., Agilent Technologies Inc., Hologic Inc., Leica Microsystems Nussloch GmbH, Cole-Parmer Instrument Company LLC, Sakura Finetechnical Company Ltd., Biogenex Laboratories Inc., StatLab Medical Products Inc., Biocare Medical LLC, Andwin Scientific, A. Menarini Diagnostics S.r.l, Milestone Medical Inc., Diapath S.p.A., PolyScience Inc., CellPath USA, Medite Medical GmbH, Histo-Line Laboratories s.r.l., Hacker Instruments & Industries Inc., Amos Scientific Pty. Ltd., TissueGnostics GmbH, Konfoong Bioinformation Tech Co. Ltd., Labstac USA, Intelsint Srl.

North America was the largest region in the histology and cytology market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the histology and cytology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the histology and cytology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Histology and cytology are interrelated branches of biology and medicine that focus on the microscopic study of tissues and cells, respectively. Histology examines tissue samples under a microscope to identify abnormalities in tissue architecture and cellular organization, aiding in diagnosing conditions such as cancer, inflammatory diseases, and infections. Cytology analyzes individual cells, often obtained from body fluids or fine needle aspirations, to detect cellular changes indicative of diseases such as cancer, infections, and autoimmune disorders. Together, histology and cytology provide comprehensive insights into disease processes, enable early detection, guide treatment decisions, and monitor the effectiveness of therapies, ultimately improving patient outcomes.

The primary products of histology and cytology include instruments, analysis software systems, consumables, and reagents. Instruments and analysis software systems are integrated hardware and software solutions designed for acquiring, processing, and interpreting data in scientific and technical fields. Various test types include microscopy methods, flow cytometry, and molecular genetic methods. The applications encompass drug discovery and design, clinical diagnostics, and academic research. These products are utilized by multiple end users, such as pharmaceutical and biotech companies, contract development and manufacturing organizations (CDMOs), diagnostic laboratories, and other related entities.

The histology and cytology market research report is one of a series of new reports that provides histology and cytology market statistics, including histology and cytology industry global market size, regional shares, competitors with a histology and cytology market share, detailed histology and cytology market segments, market trends and opportunities, and any further data you may need to thrive in the histology and cytology industry. This histology and cytology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The histology and cytology market includes revenues earned by entities by entities by providing services such as screening tests, clinical diagnostics, academic research, and drug discovery and designing to detect and classify cancerous cells and related tissue processing equipment, staining reagents, histological slides, immunohistochemistry (IHC), liquid-based cytology systems, and cytology slide preparation equipment. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.